Related Experiment Video
Updated: May 9, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Polymorphic mutations in mouse mitochondrial DNA regulate a tumor phenotype
Gaku Takibuchi1, Hirotake Imanishi, Mami Morimoto
1Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8572, Japan.
Abstract:
To examine whether polymorphic mtDNA mutations that do not induce significant respiration defects regulate phenotypes of tumor cells, we used mouse transmitochondrial tumor cells (cybrids) with nuclear DNA from C57BL/6 (B6) strain and mtDNA from allogenic C3H strain. The results showed that polymorphic mutations of C3H mtDNA in the cybrids induced hypoxia sensitivity, resulting in a delay of tumor formation on their subcutaneous inoculation into B6 mice. Therefore, the effects of polymorphic mutations in normal mtDNA have to be carefully considered, particularly when we apply the gene therapy to the embryos to replace their pathogenic mtDNA by normal mtDNA.
Insights
Polymorphic mitochondrial DNA (mtDNA) mutations can influence tumor cell behavior and slow tumor growth. These findings are crucial for gene therapy considerations involving mtDNA replacement.
Area of Science:
- Mitochondrial genetics
- Cancer biology
- Cellular respiration
Background:
- Polymorphic mitochondrial DNA (mtDNA) mutations are common.
- The impact of non-respiratory-defect-inducing mtDNA mutations on tumor phenotypes is not fully understood.
- Mitochondrial dysfunction is implicated in cancer development.
Purpose of the Study:
- To investigate if polymorphic mtDNA mutations, without causing significant respiration defects, regulate tumor cell phenotypes.
- To determine the effect of specific allogenic mtDNA on tumor cell behavior and growth.
Main Methods:
- Utilized mouse transmitochondrial tumor cells (cybrids).
- These cybrids possessed nuclear DNA from the C57BL/6 (B6) strain and mitochondrial DNA (mtDNA) from the allogenic C3H strain.
- Tumorigenicity was assessed by subcutaneous inoculation into B6 mice.
Main Results:
- Polymorphic mutations present in the C3H mtDNA within the cybrids induced hypoxia sensitivity.
- This induced hypoxia sensitivity led to a delay in tumor formation after subcutaneous inoculation.
- The presence of specific polymorphic mtDNA mutations altered tumor cell behavior.
Conclusions:
- Polymorphic mtDNA mutations, even those not causing major respiration defects, can significantly influence tumor cell phenotypes.
- The findings highlight the importance of considering the effects of polymorphic mutations in normal mtDNA.
- Careful consideration is needed when applying gene therapy for mtDNA replacement, especially in embryonic contexts.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Abnormal Proliferation
Animal Mitochondrial Genetics
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

